Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novartis reports new NPY antagonists with selectivity for Y5 receptors

Aug. 1, 1997

Clinical trial of Lipitor for the reduction of cholesterol in women

July 31, 1997

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

July 31, 1997

Troglitazone approved in the U.K.

July 31, 1997

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

July 31, 1997

Antiobesity drug therapy

July 31, 1997

Clinical pharmacokinetics, safety and efficacy of orlistat

July 31, 1997

Licenses offered for cell replication technology

July 30, 1997

FDA approves Niaspan for the treatment of mixed lipid disorders

July 30, 1997

Research Triangle Institute investigates compounds for male fertility control

July 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...